Loading…

Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital

INTRODUCTION AND OBJECTIVESIn this retrospective study, we aimed to evaluate lymph node (LN) density in retroperitoneal lymph node dissection (RPLND) to analyze whether residual mass after chemotherapy might behave as predicting factor for recurrence in patients with germ cell testicular cancer (GCT...

Full description

Saved in:
Bibliographic Details
Published in:Actas urológicas españolas (English ed.) 2021-01, Vol.45 (1), p.30-38
Main Authors: Sarikaya, S, Karsiyakali, N, Kaya, E, Topuz, B, Ebiloglu, T, Zor, M
Format: Article
Language:eng ; spa
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 38
container_issue 1
container_start_page 30
container_title Actas urológicas españolas (English ed.)
container_volume 45
creator Sarikaya, S
Karsiyakali, N
Kaya, E
Topuz, B
Ebiloglu, T
Zor, M
description INTRODUCTION AND OBJECTIVESIn this retrospective study, we aimed to evaluate lymph node (LN) density in retroperitoneal lymph node dissection (RPLND) to analyze whether residual mass after chemotherapy might behave as predicting factor for recurrence in patients with germ cell testicular cancer (GCTC). MATERIALS AND METHODSThe data of 185 patients that were operated between 12/2004 and 02/2017 because of GCTC were reviewed retrospectively. LN density was calculated. The patients were compared statistically in terms of demographic features, tumor characteristics, serum tumor marker levels, treatment strategies, and pathological results according to GCTC subtypes. Correlation analysis was performed to determine the parameters related to recurrent disease. RESULTSThe median follow-up was 79 (31-179) months and the median age of the patients was 23 (16-71). The median tumor size was 4 (1-18) cm. Five (2.7%) patients had metastatic disease at initial diagnosis. Seminoma, non-seminomatous-GCT and mix type-GCTC was detected in 62 (33.5%), 60 (32.4%) and 63 (34.1%) patients, respectively. Following inguinal orchiectomy, 48 (25.9%) patients underwent follow-up, 126 (68.1%) patients underwent chemotherapy and 11 (5.9%) patients underwent radiotherapy. A total of 21 (11.4%) patients underwent post-chemotherapy RPLND. Early and late recurrence was seen in 3 (1.6%) and 2 (1.1%) of the patients, respectively. A mild to moderate, negative, but significant correlation was found between the recurrence and the number of LNs containing metastatic deposits and LN density (r= -0.490, P=.024 and r= -0.450, P=.041, respectively). CONCLUSIONSThere was a negative correlation between the number of LNs containing metastatic deposits and LN density and recurrent disease.
doi_str_mv 10.1016/j.acuro.2020.03.014
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_2448637134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2448637134</sourcerecordid><originalsourceid>FETCH-LOGICAL-p188t-3f900b452b5f9ac969b3eba419ba893fc76961ee64798e40b743a46cdf73971d3</originalsourceid><addsrcrecordid>eNpNj8Fu2zAMho0BA1ZkeYJdeNzFnmQpstVbEbTbgAC9tOeClulErSK5ktwt77yHmJLtUF5IkD9_fqyqL5w1nHH17blBs8TQtKxlDRMN4_JDddXyTtSbrlefqnVKz6yEkmKjxVX1Z3c6zgfwYSQYySebT2A9RMoxzBRtDp7QgXunsimRyTZ4wARYmm_k4IjxhSJMIcIcabRF4PfFptBE8obOpjNmSz4n-GXzAfYUj2DIOciUsjWLwwgGizZew02pEtUm-MLhIOVlPAH6EVzw-zpfVp311hQ2-n0GvRwJUwEq02wxnsr1iWIsikNIs83oPlcfJ3SJ1v_zqnq8u33Y_qh3999_bm929cz7Ptdi0owNctMOm0mj0UoPggaUXA_YazGZTmnFiZTsdE-SDZ0UKJUZp07ojo9iVX395zvH8LqU756ONp1fRU9hSU-tlL0SHRdS_AUAno7D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2448637134</pqid></control><display><type>article</type><title>Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital</title><source>ScienceDirect Journals</source><creator>Sarikaya, S ; Karsiyakali, N ; Kaya, E ; Topuz, B ; Ebiloglu, T ; Zor, M</creator><creatorcontrib>Sarikaya, S ; Karsiyakali, N ; Kaya, E ; Topuz, B ; Ebiloglu, T ; Zor, M</creatorcontrib><description>INTRODUCTION AND OBJECTIVESIn this retrospective study, we aimed to evaluate lymph node (LN) density in retroperitoneal lymph node dissection (RPLND) to analyze whether residual mass after chemotherapy might behave as predicting factor for recurrence in patients with germ cell testicular cancer (GCTC). MATERIALS AND METHODSThe data of 185 patients that were operated between 12/2004 and 02/2017 because of GCTC were reviewed retrospectively. LN density was calculated. The patients were compared statistically in terms of demographic features, tumor characteristics, serum tumor marker levels, treatment strategies, and pathological results according to GCTC subtypes. Correlation analysis was performed to determine the parameters related to recurrent disease. RESULTSThe median follow-up was 79 (31-179) months and the median age of the patients was 23 (16-71). The median tumor size was 4 (1-18) cm. Five (2.7%) patients had metastatic disease at initial diagnosis. Seminoma, non-seminomatous-GCT and mix type-GCTC was detected in 62 (33.5%), 60 (32.4%) and 63 (34.1%) patients, respectively. Following inguinal orchiectomy, 48 (25.9%) patients underwent follow-up, 126 (68.1%) patients underwent chemotherapy and 11 (5.9%) patients underwent radiotherapy. A total of 21 (11.4%) patients underwent post-chemotherapy RPLND. Early and late recurrence was seen in 3 (1.6%) and 2 (1.1%) of the patients, respectively. A mild to moderate, negative, but significant correlation was found between the recurrence and the number of LNs containing metastatic deposits and LN density (r= -0.490, P=.024 and r= -0.450, P=.041, respectively). CONCLUSIONSThere was a negative correlation between the number of LNs containing metastatic deposits and LN density and recurrent disease.</description><identifier>EISSN: 2173-5786</identifier><identifier>DOI: 10.1016/j.acuro.2020.03.014</identifier><language>eng ; spa</language><ispartof>Actas urológicas españolas (English ed.), 2021-01, Vol.45 (1), p.30-38</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sarikaya, S</creatorcontrib><creatorcontrib>Karsiyakali, N</creatorcontrib><creatorcontrib>Kaya, E</creatorcontrib><creatorcontrib>Topuz, B</creatorcontrib><creatorcontrib>Ebiloglu, T</creatorcontrib><creatorcontrib>Zor, M</creatorcontrib><title>Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital</title><title>Actas urológicas españolas (English ed.)</title><description>INTRODUCTION AND OBJECTIVESIn this retrospective study, we aimed to evaluate lymph node (LN) density in retroperitoneal lymph node dissection (RPLND) to analyze whether residual mass after chemotherapy might behave as predicting factor for recurrence in patients with germ cell testicular cancer (GCTC). MATERIALS AND METHODSThe data of 185 patients that were operated between 12/2004 and 02/2017 because of GCTC were reviewed retrospectively. LN density was calculated. The patients were compared statistically in terms of demographic features, tumor characteristics, serum tumor marker levels, treatment strategies, and pathological results according to GCTC subtypes. Correlation analysis was performed to determine the parameters related to recurrent disease. RESULTSThe median follow-up was 79 (31-179) months and the median age of the patients was 23 (16-71). The median tumor size was 4 (1-18) cm. Five (2.7%) patients had metastatic disease at initial diagnosis. Seminoma, non-seminomatous-GCT and mix type-GCTC was detected in 62 (33.5%), 60 (32.4%) and 63 (34.1%) patients, respectively. Following inguinal orchiectomy, 48 (25.9%) patients underwent follow-up, 126 (68.1%) patients underwent chemotherapy and 11 (5.9%) patients underwent radiotherapy. A total of 21 (11.4%) patients underwent post-chemotherapy RPLND. Early and late recurrence was seen in 3 (1.6%) and 2 (1.1%) of the patients, respectively. A mild to moderate, negative, but significant correlation was found between the recurrence and the number of LNs containing metastatic deposits and LN density (r= -0.490, P=.024 and r= -0.450, P=.041, respectively). CONCLUSIONSThere was a negative correlation between the number of LNs containing metastatic deposits and LN density and recurrent disease.</description><issn>2173-5786</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpNj8Fu2zAMho0BA1ZkeYJdeNzFnmQpstVbEbTbgAC9tOeClulErSK5ktwt77yHmJLtUF5IkD9_fqyqL5w1nHH17blBs8TQtKxlDRMN4_JDddXyTtSbrlefqnVKz6yEkmKjxVX1Z3c6zgfwYSQYySebT2A9RMoxzBRtDp7QgXunsimRyTZ4wARYmm_k4IjxhSJMIcIcabRF4PfFptBE8obOpjNmSz4n-GXzAfYUj2DIOciUsjWLwwgGizZew02pEtUm-MLhIOVlPAH6EVzw-zpfVp311hQ2-n0GvRwJUwEq02wxnsr1iWIsikNIs83oPlcfJ3SJ1v_zqnq8u33Y_qh3999_bm929cz7Ptdi0owNctMOm0mj0UoPggaUXA_YazGZTmnFiZTsdE-SDZ0UKJUZp07ojo9iVX395zvH8LqU756ONp1fRU9hSU-tlL0SHRdS_AUAno7D</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Sarikaya, S</creator><creator>Karsiyakali, N</creator><creator>Kaya, E</creator><creator>Topuz, B</creator><creator>Ebiloglu, T</creator><creator>Zor, M</creator><scope>7X8</scope></search><sort><creationdate>20210101</creationdate><title>Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital</title><author>Sarikaya, S ; Karsiyakali, N ; Kaya, E ; Topuz, B ; Ebiloglu, T ; Zor, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p188t-3f900b452b5f9ac969b3eba419ba893fc76961ee64798e40b743a46cdf73971d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarikaya, S</creatorcontrib><creatorcontrib>Karsiyakali, N</creatorcontrib><creatorcontrib>Kaya, E</creatorcontrib><creatorcontrib>Topuz, B</creatorcontrib><creatorcontrib>Ebiloglu, T</creatorcontrib><creatorcontrib>Zor, M</creatorcontrib><collection>MEDLINE - Academic</collection><jtitle>Actas urológicas españolas (English ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarikaya, S</au><au>Karsiyakali, N</au><au>Kaya, E</au><au>Topuz, B</au><au>Ebiloglu, T</au><au>Zor, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital</atitle><jtitle>Actas urológicas españolas (English ed.)</jtitle><date>2021-01-01</date><risdate>2021</risdate><volume>45</volume><issue>1</issue><spage>30</spage><epage>38</epage><pages>30-38</pages><eissn>2173-5786</eissn><abstract>INTRODUCTION AND OBJECTIVESIn this retrospective study, we aimed to evaluate lymph node (LN) density in retroperitoneal lymph node dissection (RPLND) to analyze whether residual mass after chemotherapy might behave as predicting factor for recurrence in patients with germ cell testicular cancer (GCTC). MATERIALS AND METHODSThe data of 185 patients that were operated between 12/2004 and 02/2017 because of GCTC were reviewed retrospectively. LN density was calculated. The patients were compared statistically in terms of demographic features, tumor characteristics, serum tumor marker levels, treatment strategies, and pathological results according to GCTC subtypes. Correlation analysis was performed to determine the parameters related to recurrent disease. RESULTSThe median follow-up was 79 (31-179) months and the median age of the patients was 23 (16-71). The median tumor size was 4 (1-18) cm. Five (2.7%) patients had metastatic disease at initial diagnosis. Seminoma, non-seminomatous-GCT and mix type-GCTC was detected in 62 (33.5%), 60 (32.4%) and 63 (34.1%) patients, respectively. Following inguinal orchiectomy, 48 (25.9%) patients underwent follow-up, 126 (68.1%) patients underwent chemotherapy and 11 (5.9%) patients underwent radiotherapy. A total of 21 (11.4%) patients underwent post-chemotherapy RPLND. Early and late recurrence was seen in 3 (1.6%) and 2 (1.1%) of the patients, respectively. A mild to moderate, negative, but significant correlation was found between the recurrence and the number of LNs containing metastatic deposits and LN density (r= -0.490, P=.024 and r= -0.450, P=.041, respectively). CONCLUSIONSThere was a negative correlation between the number of LNs containing metastatic deposits and LN density and recurrent disease.</abstract><doi>10.1016/j.acuro.2020.03.014</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier EISSN: 2173-5786
ispartof Actas urológicas españolas (English ed.), 2021-01, Vol.45 (1), p.30-38
issn 2173-5786
language eng ; spa
recordid cdi_proquest_miscellaneous_2448637134
source ScienceDirect Journals
title Lymph node density in retroperitoneal lymph node dissection as a novel marker for predicting recurrence in patients with germ cell testicular cancer: A case-control study and long-term clinical experience of a tertiary referral hospital
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A19%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lymph%20node%20density%20in%20retroperitoneal%20lymph%20node%20dissection%20as%20a%20novel%20marker%20for%20predicting%20recurrence%20in%20patients%20with%20germ%20cell%20testicular%20cancer:%20A%20case-control%20study%20and%20long-term%20clinical%20experience%20of%20a%20tertiary%20referral%20hospital&rft.jtitle=Actas%20urol%C3%B3gicas%20espa%C3%B1olas%20(English%20ed.)&rft.au=Sarikaya,%20S&rft.date=2021-01-01&rft.volume=45&rft.issue=1&rft.spage=30&rft.epage=38&rft.pages=30-38&rft.eissn=2173-5786&rft_id=info:doi/10.1016/j.acuro.2020.03.014&rft_dat=%3Cproquest%3E2448637134%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p188t-3f900b452b5f9ac969b3eba419ba893fc76961ee64798e40b743a46cdf73971d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2448637134&rft_id=info:pmid/&rfr_iscdi=true